- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0783 - Cellules TCellules NKProgéniteurs de cellules T ou NK
Détention brevets de la classe C12N 5/0783
Brevets de cette classe: 11255
Historique des publications depuis 10 ans
|
444
|
594
|
776
|
1019
|
1158
|
1217
|
1339
|
1221
|
1244
|
720
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1156 |
685 |
| Iovance Biotherapeutics, Inc. | 341 |
249 |
| The Regents of the University of California | 19887 |
221 |
| The Trustees of the University of Pennsylvania | 4317 |
199 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2847 |
149 |
| Board of Regents, The University of Texas System | 5782 |
139 |
| Cellectis | 407 |
131 |
| Juno Therapeutics, Inc. | 406 |
112 |
| Memorial Sloan-Kettering Cancer Center | 1925 |
109 |
| Baylor College of Medicine | 945 |
103 |
| Novartis AG | 10856 |
97 |
| The Board of Trustees of the Leland Stanford Junior University | 6403 |
96 |
| City of Hope | 988 |
84 |
| Autolus Limited | 252 |
83 |
| Immunitybio, Inc. | 369 |
76 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 940 |
75 |
| Kite Pharma, Inc. | 411 |
74 |
| Regents of the University of Minnesota | 2690 |
72 |
| FATE Therapeutics, Inc. | 203 |
68 |
| Kyoto University | 2800 |
64 |
| Autres propriétaires | 8369 |